Prevalence of Fungal Infection in Patients Undergoing Oral Cavity Surgery Without Treatment With Antifungal Drug Clinical Trial
Official title:
Fungal Infection After Oral Cavity Surgeries
| Verified date | May 2020 |
| Source | Rambam Health Care Campus |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
this prospective study we will examine the prevalence of fungal infection in patients undergoing oral cavity surgery without treatment with antifungal drug
| Status | Not yet recruiting |
| Enrollment | 80 |
| Est. completion date | May 1, 2022 |
| Est. primary completion date | May 1, 2022 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Age over 18 Exclusion Criteria: - Previous oral cavity surgery. - Previous radiotherapy to the head and neck. - Previous treatment with antifungal drugs in the 30 days preceding the surgery Immunocompomised state at the date of surgery. - Pregnancy - Lack of follow-up |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Rambam Health Care Campus |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | prevalence of fungal infection in patients undergoing oral cavity surgery without treatment with antifungal drug. | 40 patients undergoing oral cavity surgery and 40 patients (control group) undergoing thyroidectomy or parotidectomy for our research measurement :Throat culture for fungal pathogens | 2 years |